Taiwan Trials 2013

Taiwan Trials 2013 will be the ONLY focused clinical trial platform in Taiwan. It will bring together pharma, biotechs, CROs, regulators and hospitals as well as technology and solution providers from Taiwan and the rest of the world to assess and explore the opportunities and potentials of offshoring and outsourcing clinical trials in Taiwan, as well as to foster regional and global partnerships for cost-effective clinical development.

Conference speakers include:

Benjamin Ing-Tiau Kuo, Chairperson, Human Subject Protection Association, Taiwan

Carlos Linn, Regional Medical Director, Oncology, Asia/China, Emerging Markets, Pfizer Inc., China

Catherine Yi-San Lee, Executive Director, Area Head of Clinical Trials Support and Compliance Asia, Pfizer Inc.

Chin-Fu Hsiao, Director of the Division of Clinical Trials Statistics, National Health Research Institutes, Taiwan

Choo Beng Goh, Medical Director, GlaxoSmithKline, Taiwan

Churn Shiouh Gau, Executive Director, Center for Drug Evaluation, Taiwan

Chyong Huey Lai, Chang Gung Memorial Hospital, Taiwan

Gregory Liu, Head of Medical Department, Oncology Business Unit,  TTY Biopharm, Taiwan and Clinical Research Director, TOT Biopharm, China

Ho Jin Oh, Assistant Director, Clinical Trial Management Division, Food and Drug Administration, Korea

Hui-Ling Shieh, Medical Director, Yung Shin Pharm Ind. Co., Taiwan

Hung Jen Lai, Medical Director, Merck Sharp and Dohme, Taiwan

James Garner, Vice President and General Manager, Takeda Global Research and Development Center (Asia), Singapore

Ko-Chung Lin, Founder and Chief Executive Officer, PharmaEssentia, Taiwan

Min-Hsiung Kao, Clinical Operation Director, Taiwan Liposome Company Ltd, Taiwan

Ming-Chu Hsu, Founder, Chairman and CEO, TaiGen Biotechnology, Taiwan

Rosalind Lu, Asia-Pacific Regional Head for Roche Product Development Global Operation Country Clinical Operation, Roche Pharmaceuticals, Taiwan

Wim Swyzen, Regional Vice President for Global Clinical Operations for Asia Pacific, Janssen, Singapore

Wing-Kai Chan, Director, National Clinical Trials and Research Center, National Taiwan Univeristy, Taiwan

Yoshiya Oda, President of Biomarkers and Personalized Medicine Unit, Eisai Inc., USA

编辑： 陈